432 related articles for article (PubMed ID: 31780644)
1. Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis.
Gagliardi M; Cotella D; Santoro C; Corà D; Barlev NA; Piacentini M; Corazzari M
Cell Death Dis; 2019 Nov; 10(12):902. PubMed ID: 31780644
[TBL] [Abstract][Full Text] [Related]
2. Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases.
Mahmud Z; Asaduzzaman M; Kumar U; Masrour N; Jugov R; Coombes RC; Shousha S; Hu Y; Lam EW; Yagüe E
Biochem Pharmacol; 2019 May; 163():391-403. PubMed ID: 30862505
[TBL] [Abstract][Full Text] [Related]
3. Acetaminophen sensitizing erastin-induced ferroptosis via modulation of Nrf2/heme oxygenase-1 signaling pathway in non-small-cell lung cancer.
Gai C; Yu M; Li Z; Wang Y; Ding D; Zheng J; Lv S; Zhang W; Li W
J Cell Physiol; 2020 Apr; 235(4):3329-3339. PubMed ID: 31541463
[TBL] [Abstract][Full Text] [Related]
4. FSP1 is a predictive biomarker of osteosarcoma cells' susceptibility to ferroptotic cell death and a potential therapeutic target.
Panczyszyn E; Saverio V; Monzani R; Gagliardi M; Petrovic J; Stojkovska J; Collavin L; Corazzari M
Cell Death Discov; 2024 Feb; 10(1):87. PubMed ID: 38368399
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis-inducing agents enhance TRAIL-induced apoptosis through upregulation of death receptor 5.
Lee YS; Lee DH; Jeong SY; Park SH; Oh SC; Park YS; Yu J; Choudry HA; Bartlett DL; Lee YJ
J Cell Biochem; 2019 Jan; 120(1):928-939. PubMed ID: 30160785
[TBL] [Abstract][Full Text] [Related]
6. Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death.
Probst L; Dächert J; Schenk B; Fulda S
Biochem Pharmacol; 2017 Sep; 140():41-52. PubMed ID: 28595877
[TBL] [Abstract][Full Text] [Related]
7. CISD3 inhibition drives cystine-deprivation induced ferroptosis.
Li Y; Wang X; Huang Z; Zhou Y; Xia J; Hu W; Wang X; Du J; Tong X; Wang Y
Cell Death Dis; 2021 Sep; 12(9):839. PubMed ID: 34497268
[TBL] [Abstract][Full Text] [Related]
8. miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma.
Zhang K; Wu L; Zhang P; Luo M; Du J; Gao T; O'Connell D; Wang G; Wang H; Yang Y
Mol Carcinog; 2018 Nov; 57(11):1566-1576. PubMed ID: 30035324
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma.
Corazzari M; Rapino F; Ciccosanti F; Giglio P; Antonioli M; Conti B; Fimia GM; Lovat PE; Piacentini M
Cell Death Differ; 2015 Jun; 22(6):946-58. PubMed ID: 25361077
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-Induced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and Apoptosis.
Lee YS; Lee DH; Choudry HA; Bartlett DL; Lee YJ
Mol Cancer Res; 2018 Jul; 16(7):1073-1076. PubMed ID: 29592897
[TBL] [Abstract][Full Text] [Related]
11. Artesunate activates the ATF4-CHOP-CHAC1 pathway and affects ferroptosis in Burkitt's Lymphoma.
Wang N; Zeng GZ; Yin JL; Bian ZX
Biochem Biophys Res Commun; 2019 Nov; 519(3):533-539. PubMed ID: 31537387
[TBL] [Abstract][Full Text] [Related]
12. Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis.
Penning TM
Chem Res Toxicol; 2017 Jan; 30(1):162-176. PubMed ID: 27806574
[TBL] [Abstract][Full Text] [Related]
13. Differential cell death decisions in the testis: evidence for an exclusive window of ferroptosis in round spermatids.
Bromfield EG; Walters JLH; Cafe SL; Bernstein IR; Stanger SJ; Anderson AL; Aitken RJ; McLaughlin EA; Dun MD; Gadella BM; Nixon B
Mol Hum Reprod; 2019 May; 25(5):241-256. PubMed ID: 30865280
[TBL] [Abstract][Full Text] [Related]
14. Active mixture of serum-circulating small molecules selectively inhibits proliferation and triggers apoptosis in cancer cells via induction of ER stress.
Scheffer D; Kulcsár G; Nagyéri G; Kiss-Merki M; Rékási Z; Maloy M; Czömpöly T
Cell Signal; 2020 Jan; 65():109426. PubMed ID: 31669205
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells.
Matsunaga T; Kawabata S; Yanagihara Y; Kezuka C; Kato M; Morikawa Y; Endo S; Chen H; Iguchi K; Ikari A
Chem Biol Interact; 2019 Dec; 314():108839. PubMed ID: 31563593
[TBL] [Abstract][Full Text] [Related]
16. New insight into the role of metabolic reprogramming in melanoma cells harboring BRAF mutations.
Ferretta A; Maida I; Guida S; Azzariti A; Porcelli L; Tommasi S; Zanna P; Cocco T; Guida M; Guida G
Biochim Biophys Acta; 2016 Nov; 1863(11):2710-2718. PubMed ID: 27542908
[TBL] [Abstract][Full Text] [Related]
17. BRAF Inhibitors Amplify the Proapoptotic Activity of MEK Inhibitors by Inducing ER Stress in NRAS-Mutant Melanoma.
Niessner H; Sinnberg T; Kosnopfel C; Smalley KSM; Beck D; Praetorius C; Mai M; Beissert S; Kulms D; Schaller M; Garbe C; Flaherty KT; Westphal D; Wanke I; Meier F
Clin Cancer Res; 2017 Oct; 23(20):6203-6214. PubMed ID: 28724666
[No Abstract] [Full Text] [Related]
18. Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma.
Audrito V; Managò A; La Vecchia S; Zamporlini F; Vitale N; Baroni G; Cignetto S; Serra S; Bologna C; Stingi A; Arruga F; Vaisitti T; Massi D; Mandalà M; Raffaelli N; Deaglio S
J Natl Cancer Inst; 2018 Mar; 110(3):. PubMed ID: 29309612
[TBL] [Abstract][Full Text] [Related]
19. Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3.
Shintoku R; Takigawa Y; Yamada K; Kubota C; Yoshimoto Y; Takeuchi T; Koshiishi I; Torii S
Cancer Sci; 2017 Nov; 108(11):2187-2194. PubMed ID: 28837253
[TBL] [Abstract][Full Text] [Related]
20. Ferroptosis: a new unexpected chance to treat metastatic melanoma?
Gagliardi M; Saverio V; Monzani R; Ferrari E; Piacentini M; Corazzari M
Cell Cycle; 2020 Oct; 19(19):2411-2425. PubMed ID: 32816618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
